Edition:
India

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

390JPY
19 Jan 2018
Change (% chg)

¥6 (+1.56%)
Prev Close
¥384
Open
¥384
Day's High
¥402
Day's Low
¥383
Volume
2,918,800
Avg. Vol
5,204,201
52-wk High
¥652
52-wk Low
¥219

Latest Key Developments (Source: Significant Developments)

Pledpharma and Solasia enter license agreement on Pledox in Asia
Monday, 20 Nov 2017 

Nov 20 (Reuters) - PLEDPHARMA AB (PUBL) :PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA .PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY UPFRONT, DEVELOPMENT, REGULATORY AND SALES MILESTONES OF UP TO ABOUT USD 83 MILLION​.PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY INDUSTRY STANDARD ROYALTY RATES ON SALES​.PLEDPHARMA AB (PUBL) - ‍WILL ALSO FULLY FINANCE AN EXPANSION OF PHASE III PROGRAM FOR PLEDOX​.‍TOTAL VALUE OF UPFRONT AND MILESTONE PAYMENTS IS UP TO JPY 9.3 BILLION​.‍PHASE III STUDIES ANTICIPATED TO BE INITIATED END OF 2017 WITH TOP LINE RESULTS EXPECTED IN 2020​.  Full Article

BRIEF-Pledpharma and Solasia enter license agreement on Pledox in Asia

* PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA